Intellia Therapeutics Inc (NTLA) — Net Asset Quality Index
Intellia Therapeutics Inc (NTLA) has a Net Asset Quality Index of 79.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $842.13 Million minus total liabilities of $170.73 Million yields net assets of $671.39 Million. A higher index indicates a stronger, lower-leverage balance sheet. See NTLA days of operational coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Intellia Therapeutics Inc Net Asset Quality Index Over Time (2014–2025)
This chart shows how Intellia Therapeutics Inc's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the index stands at 79.7%, representing net assets of $671.39 Million against total assets of $842.13 Million USD. Explore cash flow conversion of Intellia Therapeutics Inc to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Intellia Therapeutics Inc (2014–2025)
The table below presents the year-by-year Net Asset Quality Index for Intellia Therapeutics Inc from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Intellia Therapeutics Inc market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 79.7% | $671.39 Million | $842.13 Million | $170.73 Million | ▲ +6.5 pp |
| 2024 | 73.2% | $871.96 Million | $1.19 Billion | $319.06 Million | ▼ -7.5 pp |
| 2023 | 80.7% | $1.05 Billion | $1.30 Billion | $250.81 Million | ▼ -0.6 pp |
| 2022 | 81.3% | $1.24 Billion | $1.52 Billion | $284.53 Million | ▲ +0.9 pp |
| 2021 | 80.4% | $1.04 Billion | $1.29 Billion | $254.22 Million | ▲ +2.4 pp |
| 2020 | 77.9% | $527.07 Million | $676.32 Million | $149.25 Million | ▼ -2.8 pp |
| 2019 | 80.7% | $269.88 Million | $334.28 Million | $64.40 Million | ▲ +0.7 pp |
| 2018 | 80.0% | $277.92 Million | $347.31 Million | $69.39 Million | ▲ +0.1 pp |
| 2017 | 79.9% | $300.60 Million | $376.24 Million | $75.64 Million | ▲ +9.7 pp |
| 2016 | 70.2% | $209.84 Million | $298.97 Million | $89.13 Million | ▼ -11.8 pp |
| 2015 | 82.0% | $67.36 Million | $82.14 Million | $14.78 Million | ▲ +11.3 pp |
| 2014 | 70.7% | $7.57 Million | $10.69 Million | $3.13 Million | — |